Human RAGE Quantikine ELISA Kit
| Name | Human RAGE Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DRG00 |
| Category | ELISA Kit |
| Prices | $519.00, $2,491.00, $16,868.00 |
| Sizes | 1 kit, 1 pack (6 Plates), 1 pack (50 Plates) |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (50 uL), Serum (50 uL), EDTA Plasma (50 uL), Heparin Plasma (50 uL) |
| Sensitivity | 16.14 pg/mL |
| Range | 78.0 - 5,000 pg/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human RAGE Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human RAGE (extracellular domain) in cell culture supernates, serum, and plasma |
| Gene | AGER |
| Supplier Page | Shop |
Product images
Product References
Club cell protein 16 and cytokeratin fragment 21-1 as early predictors of - Club cell protein 16 and cytokeratin fragment 21-1 as early predictors of
Negrin LL, Halat G, Kettner S, Gregori M, Ristl R, Hajdu S, Heinz T. PLoS One. 2017 Apr 5;12(4):e0175303.
Innovative Flow Cytometry Allows Accurate Identification of Rare Circulating - Innovative Flow Cytometry Allows Accurate Identification of Rare Circulating
Boraldi F, Bartolomeo A, De Biasi S, Orlando S, Costa S, Cossarizza A, Quaglino D. PLoS One. 2016 Aug 25;11(8):e0160153.
Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year - Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year
Heier M, Margeirsdottir HD, Gaarder M, Stensaeth KH, Brunborg C, Torjesen PA, Seljeflot I, Hanssen KF, Dahl-Jorgensen K. Cardiovasc Diabetol. 2015 Sep 25;14:126.
Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in - Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in
Jabaudon M, Blondonnet R, Roszyk L, Pereira B, Guerin R, Perbet S, Cayot S, Bouvier D, Blanchon L, Sapin V, Constantin JM. PLoS One. 2015 Aug 14;10(8):e0135857.
Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated - Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated
Lee AC, Lam JK, Shiu SW, Wong Y, Betteridge DJ, Tan KC. PLoS One. 2015 Sep 1;10(9):e0137330.
Higher serum soluble receptor for advanced glycation end product levels and lower - Higher serum soluble receptor for advanced glycation end product levels and lower
Momma H, Niu K, Kobayashi Y, Huang C, Chujo M, Otomo A, Tadaura H, Miyata T, Nagatomi R. Diabetol Metab Syndr. 2014 Mar 6;6(1):33.
Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH. - Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH.
Moser B, Megerle A, Bekos C, Janik S, Szerafin T, Birner P, Schiefer AI, Mildner M, Lang I, Skoro-Sajer N, Sadushi-Kolici R, Taghavi S, Klepetko W, Ankersmit HJ. PLoS One. 2014 Sep 4;9(9):e106440.
GeneOptimizer program-assisted cDNA reengineering enhances sRAGE autologous - GeneOptimizer program-assisted cDNA reengineering enhances sRAGE autologous
Wei W, Kim JM, Medina D, Lakatta EG, Lin L. Protein Expr Purif. 2014 Mar;95:143-8.
The impact of concomitant pulmonary infection on immune dysregulation in - The impact of concomitant pulmonary infection on immune dysregulation in
Chou CW, Lin FC, Tsai HC, Chang SC. BMC Pulm Med. 2014 Nov 19;14:182.
Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor - Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor
Zakiyanov O, Kriha V, Vachek J, Zima T, Tesar V, Kalousova M. BMC Nephrol. 2013 Nov 4;14:245.